Details for New Drug Application (NDA): 216977
✉ Email this page to a colleague
The generic ingredient in NALOXONE HYDROCHLORIDE is naloxone hydrochloride; pentazocine hydrochloride. There are twelve drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride; pentazocine hydrochloride profile page.
Summary for 216977
Tradename: | NALOXONE HYDROCHLORIDE |
Applicant: | Bpi Labs |
Ingredient: | naloxone hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 216977
Mechanism of Action | Opioid Antagonists |
Medical Subject Heading (MeSH) Categories for 216977
Suppliers and Packaging for NDA: 216977
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NALOXONE HYDROCHLORIDE | naloxone hydrochloride | INJECTABLE;INJECTION | 216977 | ANDA | BPI Labs LLC | 54288-124 | 54288-124-01 | 1 PACKAGE in 1 CARTON (54288-124-01) / 2 mL in 1 PACKAGE |
NALOXONE HYDROCHLORIDE | naloxone hydrochloride | INJECTABLE;INJECTION | 216977 | ANDA | BPI Labs LLC | 54288-124 | 54288-124-10 | 10 PACKAGE in 1 CARTON (54288-124-10) / 2 mL in 1 PACKAGE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML | ||||
Approval Date: | Oct 6, 2023 | TE: | AP | RLD: | No |
Complete Access Available with Subscription